ReviewAlzheimer's research & therapy2022

Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer's disease.

Randall J Bateman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.